Trials / Recruiting
RecruitingNCT07464132
Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases
- Status
- Recruiting
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Peking Union Medical College Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to conduct clinical research on \[68Ga\] Ga-NI-FAPI-04 PET/CT imaging and further investigate its diagnostic value in fibroblast activation related diseases.
Conditions
- Tumor
- Cardiovascular Diseases
- Pulmonary Fibrosis
- Rheumatic Immune Diseases Involving Large Blood Vessels
- Hypertrophic Cardiomyopathy (HCM)
- Other Hypoxic and Fibroblast Activated Diseases
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Injection of 68Ga-NI-FAPI | Subjects were injected with 68Ga-NI-FAPI at 0.4-0.5mci/kg body weight |
Timeline
- Start date
- 2025-12-17
- Primary completion
- 2027-02-17
- Completion
- 2027-06-17
- First posted
- 2026-03-11
- Last updated
- 2026-03-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07464132. Inclusion in this directory is not an endorsement.